Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Stemline Therapeutics, Inc.
Maastricht University Medical Center
Silesian Centre for Heart Diseases
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Concure Oncology-Breast Microseed Inc.